The interaction of herpes simplex virus (HSV) with its human host can result in one or more cell-virus interactions that include cytocidal infection (40) , latent infection (4, 41) , and cellular transformation (16, 32) . Because the latent HSV genome can be harbored in humans and can be reactivated to produce recurrent clinical disease, establishment and maintenance of virus latency and reactivation are current foci of research. To date, these studies have employed human tissue (3, 11, 12, 42) and both in vitro (13, 19, 29, (49) (50) (51) and in vivo (30, 41) model systems. In addition, as HSV has been implicated in the etiology of certain human cancers (33) , the potential role of the latent HSV genome in the oncogenic process is currently being assessed.
We have previously described infections of human embryo lung fibroblast (HEL-F) cells with HSV type 1 (HSV-1) or HSV type 2 (HSV-2) in which the virus genome is maintained in a repressed form by increased temperature after virus replication is partially blocked by treatment with 1-3-D-arabinofuranosylcytosine (ara-C; 6, 7, 24, 43, 44) .
Infectious center assays indicate that less than 0.0002 to 0.02% of the cell population contains a virus genome that can be reactivated (7, 24, 44) . To analyze the molecular aspects of establishment and maintenance of the virus latency and reactivation processes, it was essential for us to increase the fraction of the cell population containing an HSV genome that could be activated into a productive replication cycle.
Recent studies have used human leukocyte interferon (IFN-oQ) in combination with the relatively noncytotoxic (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU; [8] [9] [10] and increased temperature (40.5°C) to establish and maintain the HSV-1 genome in a repressed form after high-multiplicity infection of HEL-F cells with HSV-1 (45) . BVDU is known to inhibit viral DNA polymerase (2) , although it can also be * Corresponding author.
incorporated into virus DNA (1, 21) , presumably by interfering with expression of HSV late or y genes (14, 17) and possibly a subset of HSV early or 3 genes (14, 17) , while allowing complete expression of the immediate early ox genes (14, 17) . In addition, human interferon blocks the deleterious effects of HSV on human chromosomes (25, 26) . As described with repressed HSV-1 or HSV-2 infections established by ara-C treatment (6, 7, 43, 44) , HSV-1 can be activated either by reducing the temperature or superinfecting with human cytomegalovirus. However, combined IFNo and BVDU treatment resulted in an increase in the minimum number of cells (from 0.02 to 3%) that can be activated to produce infectious HSV-1 (45) . Because HEL-F cells were used as the host cell, the validity of this in vitro latency model was further assessed in a cell of neuronal origin (46) . BVDU or combination BVDU and IFN-ot treatment of HSV-1-infected rat fetal neurons isolated from the dorsal root ganglia repressed HSV-1 replication. Analogous to repressed HSV-1 infections in HEL-F cells (45) , the HSV-1 genome was maintained in a repressed form in rat fetal neurons by increasing the incubation temperature to 40 .5°C after inhibitors were removed. In addition, virus was predictably reactivated from neurons by reducing the incubation temperature to 37°C. In this study, we examined the HSV-1 genome (i) during establishment and maintenance of the repressed infection in HEL-F cells, (ii) during maintenance of the repressed infection in rat fetal neurons, and (iii) during reactivation.
MATERIALS AND METHODS
Cells and viruses. Monolayer cultures of HEL-F, primary rabbit kidney (PRK), and baby hamster kidney-21 (BHK-21) cells were grown as previously described (6, 7, 43, 44, 50, 51) . Neuron cell cultures were prepared as previously de- scribed (5, 48, 50, 51 10 FLM uridine and the mitotic inhibitors ara-C (10 FiM) and fluorodeoxyuridine (10 FM) . The neuron cell cultures were subsequently alternated at 24-h intervals between E-MEM (10/10) and E-MEM (10/10) containing uridine and mitotic inhibitors for 7 days. Before use, neuron cell cultures were maintained for 2 to 4 days in E-MEM (10/ 10). After treatment of neuron cell cultures with uridine and mitotic inhibitors, cultures consisted of greater than 99.9% neurons with only an occasional contaminating fibroblast or Schwann cell. Such contaminating cells had aberrant nuclear and cytoplasmic morphology as a result of treatment with mitotic inhibitors. Only neuron cell cultures of 99.9% or greater purity were used for experimentation.
HSV-1 (strain Patton) stocks were obtained by replication in HEL-F cells as described previously (6, 7, 43, 44) , and HEL-F mock-infecting fluid was prepared from uninfected HEL-F cells in a manner analogous to the preparation of the virus stock (6, 7, 43, 44) . Infectious HSV-1 was quantitated by plaque assay on HEL-F, PRK, or BHK-21 cells (6, 7).
Establishment and maintenance of HSV-1 genome in repressed form and virus reactivation. The procedure for the establishment and maintenance of the HSV-1 genome in repressed form was performed essentially as previously described for HEL-F cells (45) or rat fetal neurons (46 (18, 22, 36) . The HSV-1 EcoRI DNA fragments were cloned into X and pACYC184 vectors, whereas the HSV-1 HindlIl and BamHI DNA fragments were cloned into pBR322. HSV-1 recombinant plasmids were purified as described previously (8) . HSV-1 DNA was purified from virions isolated from infected cells as described previously (7, 43, 44) .
Isolation of cell DNA. DNA was extracted from neurons or HEL-F cells as previously described (47) (3, 200 Ci/mmol; New England Nuclear Corp., Boston, Mass.), 125 ,Ci of [a-32P]dGTP (3, 200 Ci/mmol), 0.1 ng of DNase I (Worthington Biochemicals, Freehold, N.J.), 2 U of DNA polymerase I (Boehringer Mannheim Biochemicals), and 100 ng of DNA in a reaction volume of 0.04 ml. The reaction was carried out for 3.5 h at 14°C and then terminated, and radiolabeled DNA was purified as described previously (20, 34) . Specific activities of 5 x 108 to 2 x 109 cpm/,ug of DNA were achieved. The radiolabeled probe DNA used was a genomic proportion mixture of HSV-1 recombinant plasmids consisting of HSV-1 EcoRI D, G, N, F, M, 0, L, I, and H DNA fragments inserted in pACYC184 and HSV-1 HindIII K and L DNA fragments inserted in pBR322 (18, 22, 36) representing the entire HSV-1 long unique and short unique DNA sequences (Fig. 1) .
The HSV-1 joint region BamHI S-P (K) DNA fragment was partially purified from the recombinant plasmid, radiola- The physical map location of the BamHI S-P (K) hybridization probe DNA is indicated by the closed rectangle. The BamHI S-P (K) DNA fragment encompasses the junction of the long and short components, resulting in a single BamHI junction DNA fragment in each isomeric form. The physical map of the HSV-1 genome and the physical location of the recombinant DNA fragments have been described previously (15, 18, 22, 23, 28, 36, 38) .
beled in vitro, and also used as probe. Purification of the BamHI S-P (K) DNA fragment insert was performed to increase the sensitivity of the probe DNA to increase the probability of detecting minor species of altered HSV-1 terminal DNA fragments. pBR322 containing the HSV-1 BamHI S-P (K) DNA fragment (100 ,ug) was digested with BamHI under the conditions specified by the manufacturer (Boehringer Mannheim Biochemicals /ml ) and IFN-a (100 IU/ml) and infected with 2.5 PFU/ml of HSV-1 per cell retain the virus in a noninfectious or latent form after a 7-day treatment interval. Combined BVDU and IFN-a treatment resulted in elimination of detectable infectious HSV-1 within 3 days in both infected cell types (Fig. 2) . Infectious HSV-1 remained undetectable during the remainder of the treatment interval. After removal of the inhibitor on day 7, HSV-1 was detectable within 3 days at 37°C with progressive virusspecific cytopathology and eventual total destruction of HEL-F cell or neuron cell cultures ( Fig. 2A) . However, as reported previously (45, 46) , if the incubation temperature of HSV-1-infected, inhibitor-treated HEL-F cells or neurons was increased from 37 to 40.5°C, HSV-1 could be maintained in a noninfectious form for at least 60 or 15 days, respectively (data not shown). Replication of HSV-1 was activated in either latently infected cell type by reducing the incubation temperature from 40.5 to 37°C. Infectious virus was usually detectable within 1 to 3 days after temperature reduction, and maximum virus synthesis was attained after 4 to 7 days at 37°C (Fig. 2B) , with extensive virus-specific cytopathology.
The infectious virus synthesized after reduction of the incubation temperature of latently infected HEL-F cells from 40.5 to 37°C was identified by DNA blot hybridization to be parental-like input virus (Fig. 3) . HSV-infected HEL-F cells were treated with combined BVDU and IFN-a for 7 days and maintained at 40 tor-treated HEL-F cells 4 days after reduction of the temperature from 40.5 to 37°C. The DNA was digested with XbaI ( Fig. 3A) , BamHI (Fig. 3B ), or Hindlll (Fig. 3C) , blot transferred, and hybridized with a 32P-radiolabeled probe consisting of a genomic proportion mixture of recombinant plasmids containing the unique HSV-1 DNA sequences, and autoradiography was performed. No alterations in the reactivated virus genome (Fig. 3A, B , and C, lanes 2) were detectable by this method as compared with purified, parental input virion HSV-1 DNA (Fig. 3A, B, (Fig. 4A) or HindlIl (Fig. 4B) , subjected to electrophoresis, blot transferred, and hybridized with a 32P-radiolabeled genomic proportion mixture of recombinant plasmids containing greater than 95% of the unique HSV-1 DNA sequences (Fig. 1) , and autoradiography was performed. Most, if not all, HSV-1 unique DNA sequences from the long and short genome components were retained within the latently infected HEL-F cell population 8 days after inhibitor removal and maintenance at 40.5°C (Fig. 4) (Fig. 1) difficult to interpret because the HSV-1 virion DNA used in the reconstruction analyses was purified by two successive CsCI buoyant density equilibrium centrifugation steps and may, therefore, have reduced apparent relative molarities of larger restriction endonuclease DNA fragments.
Compared with the reconstruction analyses with purified HSV-1 extracellular virion and HEL-F cell DNAs, HSV-1 DNA fragments obtained by XbaI (Fig. 4A) probably all, unique HSV-1 DNA sequences in latently infected HEL-F cells, it was of interest to examine the form of these HSV-1 sequences. As one approach to determine whether the HSV-1 genome was present in an integrated or nonintegrated form, we used the HSV-1 BamHI S-P (K) DNA fragment as a probe (Fig. 1) to detect the authentic HSV-1 junction and terminal DNA fragments in latently infected HEL-F cells (Fig. 5) . Again, total cellular DNA was isolated from HSV-1-infected, inhibitor-treated HEL-F cells 1, 3, and 7 days after infection and after incubation at 40.5°C for 4 and 8 days after inhibitor removal. The DNAs were digested with XbaI (Fig. SA) or BamHI (Fig. 5B) , subjected to electrophoresis, blot transferred, and hybridized with the 32P-radiolabeled BarnHI S-P (K) DNA fragment, and autoradiography was performed. There was no detectable alteration in the size of the HSV-1 terminal DNA fragments obtained by digestion of latently infected HEL-F cell DNA with XbaI or BamHI as compared with the authentic terminal DNA fragments generated by digestion of the HSV-1 virion DNA in the reconstruction experiment (Fig. 5) 49, 1984 data suggest that the nonintegrated HSV-1 genome was predominantly a nonconcatameric, linear form rather than a circular or concatameric form. As determined by comparison with the reconstruction analysis, the HSV-l junction and terminal DNA fragments were retained in the latently infected HEL-F cell population at approximately 0.5 copies per haploid cell genome equivalent (Fig. 5) Detection of HSV-1 DNA sequences during virus latency in isolated rat fetal neurons. Although infectious center analysis of latently infected rat fetal neurons maintained at 40.5°C after removal of BVDU and IFN-cx has not been performed, HSV-1-specific immunofluorescence was apparent in approximately 50% of the neurons 3 days after inhibitor removal and incubation at 37°C (46) . Analogous experimentation with latently infected HEL-F cells has demonstrated that approximately 10% of the cell population expresses HSV-1 antigens early after reactivation (data not shown). To examine the latently infected rat fetal neurons for HSV-1 DNA sequences at a time when no infectious virus was detectable, blot hybridization was performed. Total cell DNA was purified from HSV-1-infected rat fetal neurons after a 7-day treatment at 37°C with combined BVDU and IFN-ao and a subsequent 4-day incubation at 40.5°C. The DNA was digested with BamHI (Fig. 6, lane 5 DNA was isolated from HSV-1-infected rat fetal neurons after a 7-day treatment with combined BVDU and IFN-a and a subsequent 4-day incubation after inhibitor removal and increase in temperature from 37 to 40.5°C, digested with BamHI, subjected to electrophoresis, blot transferred, and hybridized with a 32P-radiolabeled BamHI S-P (K) DNA fragment partially purified from the vector DNA, and autoradiography was performed (lane 5). The reconstruction experiment was performed with 2, 1, 0.5, or 0 copies of purified HSV-1 virion DNA per haploid cell genome equivalent (lanes 1 to 4, respectively). A total of 20 ,ug of an HSV-1 and HEL-F cell DNA reconstruction was then digested with BamHI and analyzed as described for lane 5. DNA (1.0 ,ug) was also isolated from HSV-1-infected rat fetal neurons electrophoresis, blot transferred, and hybridized with the 32P-radiolabeled BamHI S-P (K) DNA fragment (Fig. 1) , and autoradiography was performed (Fig. 6 ). As demonstrated with latently infected HEL-F cell DNA digested with BamHI and hybridized with the BamHI S-P (K) DNA fragment, the HSV-1 terminal DNA fragments detected in latently infected neuron DNA (Fig. 6, lane 5) were similar in size to those generated by digestion of HSV-1 virion DNA with BamHI, as shown in the reconstruction analysis (Fig. 6,  lanes 1 to 3) . Again, by comparison with the reconstruction analysis, the HSV-1 junction S-P (K) and terminal S and P DNA fragments were retained in the latently infected rat fetal neurons at 8 to 10 copies per haploid cell genome equivalent. When DNA isolated from inhibitor-treated, mock-infected neurons maintained at 40.5°C for 4 days after inhibitor removal was analyzed by analogous blot hybridization conditions, no detectable hybridization was observed (data not shown).
To compare molar ratios of the HSV-1 junction with terminal DNA fragments, densitometric analysis was performed. A densitometric scan of an autoradiographic exposure of DNA from latently infected rat fetal neuron DNA digested with BamHI and hybridized with the BamHI S-P (K) DNA fragment (Fig. 7B ) demonstrated that the molar ratios of the junction S-P (K) to the terminal S or P DNA fragment resembled those obtained by digestion of HSV-1 virion DNA in the reconstruction experiment (Fig. 7A) .
Digestion of HSV-1 DNA obtained from virions isolated from productively infected rat fetal neurons rather than HEL-F cells resulted in a similar junction-to-terminal DNA fragment molarity ratio (data not shown). This ratio contrasts with that obtained with DNA isolated from productively infected rat fetal neurons 24 h after infection, digested with BamHI, and hybridized with the BamHI S-P (K) DNA fragment (Fig. 7C) To analyze whether HSV-1 unique DNA sequences were retained to the same extent in latently infected rat fetal neurons as the junction and terminal DNA fragments, DNA was isolated from latently infected neurons after a 4-day incubation at 40.5°C, digested with BamHI, subjected to electrophoresis, and blot transferred. The DNA blots were hybridized with the 32P-radiolabeled genomic proportion mixture of recombinant plasmids (Fig. 1) containing the unique HSV DNA sequences (Fig. 8A) , the EcoRI L DNA fragment (Fig. 1) from the middle of the long unique segment (Fig. 8B) , or the EcoRI H DNA fragment (Fig. 1) encompassing the entire short unique segment (Fig. 8C) Comparison of HSV-1 junction-to-terminal DNA fragment molarity ratios by densitometric analysis. (A) HSV-1 virion and HEL-F cell reconstruction DNA (2.0 copies of HSV-1 genome per haploid cell genome equivalent) was digested with BamHl, subjected to electrophoresis, blot transferred, and hybridized with a partially purified 32P-radiolabeled BamHI S-P (K) DNA fragment; autoradiography was performed, and a 3-day exposure was analyzed by densitometry. (B) DNA was isolated from HSV-1-infected rat fetal neurons after a 7-day treatment with BVDU and IFN-a and a subsequent 4-day incubation after removal of inhibitor and increase in temperature from 37 to 40.5°C and was analyzed as described for (A) (2-day exposure of autoradiograph). (C) DNA (1.0 p.g) was isolated from HSV-1-infected rat fetal neurons 24 h postinfection and analyzed as described for (A) (3-h exposure of autoradiograph). From left to right in each panel, the peaks represent the HSV-1 BamHI K, P, and S DNA fragments, respectively. Autoradiographic exposures used for densitometric analysis were linear with respect to the film response to radioactivity. consistent with the retention of the HSV-1 junction and terminal DNA fragments but not unexpected since synthesis of HSV-1 antigens has been detected in a large proportion of the infected neuron population early after inhibitor removal and maintenance at 37°C. DISCUSSION We have previously described the design and partial biological characterization of in vitro HSV latency models with HEL-F cells and rat fetal neurons as the host cell types (45, 46) . The in vitro latent infections have been established and maintained by combined BVDU and IFN-a treatment and subsequent increased incubation temperature. Predictable reactivation of virus synthesis has been attained by reducing incubation temperature.
We now report for the first time the molecular characterization of the HSV genome during in vitro virus latency in a model system in which virus reactivation can be attained. The results suggest that the predominant form of the HSV-1 genome during in vitro virus latency in HEL-F cells or rat fetal neurons was nonintegrated, unit-length, linear DNA. However, this does not preclude the possibility of minor undetectable, yet important, HSV DNA species being retained in an integrated or nonintegrated plasmid or concatameric form.
Although substantial altered HSV-1 terminal DNA fragment species were not detected in latently infected HEL-F cell DNA, the possibility of integration of the HSV genome during in vitro virus latency cannot be completely eliminated. However, it is likely that the use of three different restriction endonucleases (XbaI, BamHI, and HindIll) would result in detection of a substantially altered HSV-1 terminal DNA fragment species, suggesting HEL-F cell DNA sequences covalently joined to HSV-1 terminal DNA fragments. Any small alteration in terminal DNA fragment size may also be attributed to reiteration of the "a" sequence in the terminal repeat region since this phenomenon has been documented in lytic in vitro HSV infection (28) . In addition, because homology has been reported between segments of HSV inverted repeat DNA sequences and repetitive sequences in mammalian cell DNA (27, 31) (35) . In addition, although the HSV-1 junction DNA fragment could be detected, authentic HSV-1 terminal DNA fragments could not be detected in total mouse brain or pooled trigeminal ganglia DNA. However, in contrast to this result, Fraser and co-workers previously detected HSV-1 terminal as well as junction DNA fragments of authentic size in human brain DNA (11) , suggesting that the HSV-1 genome is in a nonintegrated, unit-length, linear form in at least a portion of the specimens examined. The predominant nonintegrated, unit-length, linear form of the HSV-1 genome retained during virus latency in the HEL-F cell or rat fetal neuron in vitro model system resembled the form of the HSV-1 genome detected in several total brain DNA specimens by Fraser and co-workers (11) .
Present studies are directed at a delineation of the intracellular location of the HSV-1 genome during in vitro virus latency. Since the HSV-1 genome appears to be in a nonintegrated, linear form, as opposed to a plasmid or a replicating concatameric form (15, 23) , the possibility of the genome being maintained in a nucleosomal or nucleocapsid structure is also being examined. Furthermore, since Youssoufian and co-workers (49) have demonstrated that virus DNA in HSV-1 latently infected human lymphoblastoid cells contained an increased number of methylated cytosine nucleotides, the possibility of DNA methylation during virus latency is also being assessed. Although the detection of virus-specific RNA during in vitro latency (unpublished data) in rat fetal neurons would tend to argue against a DNA nucleocapsid structure at least in this model system, both in vitro HSV latency model systems are currently being analyzed for virus-specific proteins in addition to RNA.
